• No results found

Serotonin Reuptake Inhibitor

Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure

Pain Reactivity in 2-Month-Old Infants After Prenatal and Postnatal Selective Serotonin Reuptake Inhibitor Medication Exposure

... selective serotonin reuptake inhibitor– exposed in- fants [pSE], and prenatal and postnatal selective se- rotonin reuptake inhibitor– exposed infants [ppSE] groups, ...

17

Efficacy of selective serotonin reuptake inhibitor (SSRI) in patient with premature ejaculation

Efficacy of selective serotonin reuptake inhibitor (SSRI) in patient with premature ejaculation

... that serotonin (5- hydroxytryptamine, 5-HT) throughout brain descending pathways, exerts an inhibitory role on ejaculation ...(3). Serotonin is important at the level of the central nervous system in the ...

5

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment

Bioimpedance in monitoring of effects of selective serotonin reuptake inhibitor treatment

... Background: Bioimpedance has been shown to be a safe technique when used in a number of biomedical applications. In this study, we used the Electro Interstitial Scan (EIS) to perform bioimpedance measurements to follow ...

6

Validation of an UPLC-MS/MS method for simultaneous Quantification of two Selective Serotonin and nor Epinephrine Reuptake Inhibitors and one Selective Serotonin Reuptake Inhibitor in human plasma

Validation of an UPLC-MS/MS method for simultaneous Quantification of two Selective Serotonin and nor Epinephrine Reuptake Inhibitors and one Selective Serotonin Reuptake Inhibitor in human plasma

... Selective Serotonin and Nor Epinephrine Reuptake Inhibitors (Duloxetine &Venlafaxine) and one Selective Serotonin Reuptake Inhibitor (Paroxetine) in human plasma using Sertraline as ...

10

Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior

Maternal Selective Serotonin Reuptake Inhibitor Use During Pregnancy and Newborn Neurobehavior

... It is interesting that findings of this study point to evidence of both lower arousal (fewer state changes, restricted state range) and higher arousal (increased startles, tremors, motor[r] ...

10

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine

Behavioral destabilization induced by the selective serotonin reuptake inhibitor fluoxetine

... The present study demonstrated that chronic fluoxetine treatments induced a marked day-to-day fluctuation of activity levels of mice in familiar environments. This novel behavioral effec[r] ...

11

Findings From Selective Serotonin Reuptake Inhibitor–Exposed Neonates Should Be Interpreted With Caution

Findings From Selective Serotonin Reuptake Inhibitor–Exposed Neonates Should Be Interpreted With Caution

... our study on the association between maternal use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and neo- natal neurobehavior. As we described in our article, maternal depression during ...

5

Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke

Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke

... background Selective serotonin reuptake inhibitors (SSRIs) have been implicated in contributing to recovery after acute ischaemic stroke. In particular, poststroke initiation of an SSRI has been ...

8

Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives

<p>Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives</p>

... Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive ...

8

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder

Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorder

... Background: Oxytocin is known for its capacity to facilitate social bonding, reduce anxiety and for its actions on the stress hypothalamopituitary adrenal (HPA) axis. Since oxytocin can physiologically suppress activity ...

7

Hippocampal Endoplasmic Reticulum Stress: Novel Target in PTSD Pharmacotherapy?

Hippocampal Endoplasmic Reticulum Stress: Novel Target in PTSD Pharmacotherapy?

... selective serotonin reuptake inhibitor (SSRIs), the first line FDA-approved drug for PTSD, may increase the risk of suicidal ideation and suicide in patients suffering form the ...

6

Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors

Neonatal S100B Protein Levels After Prenatal Exposure to Selective Serotonin Reuptake Inhibitors

... OBJECTIVE: This study investigated neonatal S100B levels as a biomar- ker of prenatal selective serotonin reuptake inhibitor (SSRI) exposure. METHODS: Maternal (delivery; N ⫽ 53) and neonatal (cord; ...

11

Should Selective Serotonin Reuptake Inhibitors Be Prescribed for Children With Major Depressive and Anxiety Disorders?

Should Selective Serotonin Reuptake Inhibitors Be Prescribed for Children With Major Depressive and Anxiety Disorders?

... selective serotonin reuptake inhibitor; MHRA, Medicines and Healthcare Products Regulatory Agency; CDRS-R, Children’s Depression Rating Scale-Revised; TCA, tricyclic antidepressant; CGI-I, Clinical ...

6

Sertraline versus amitriptyline in
the prophylactic therapy of non-depressed chronic tension-type
headache patients

Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients

... of serotonin-specific reuptake inhibitors on ...selective serotonin reuptake inhibitor sertraline (50 mg/day) in comparison with amitriptyline (25 mg/day) in the prophylactic treatment ...

7

Antidepressant treatment response is modulated by genetic and environmental factors and their interactions

Antidepressant treatment response is modulated by genetic and environmental factors and their interactions

... One possible explanation is that antidepressant response is a multifactorial and polygenic phenotype determined by several common variants, and each individual SNP is only responsible for a small fraction of heritability ...

9

Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns

Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns

... selective serotonin-reuptake inhibitor antidepressants in utero were com- pared with those of healthy control newborns matched on gestational ...

8

Potential drug therapies for the treatment of fibromyalgia

Potential drug therapies for the treatment of fibromyalgia

... Selective serotonin enhancement has been studied with paroxetine ...selective serotonin reuptake inhibitor, in patients with ...the serotonin antagonist and reuptake ...

37

Clinical use of antidepressant therapy and associated cardiovascular risk

Clinical use of antidepressant therapy and associated cardiovascular risk

... oxidase inhibitor concentrations because of the time taken for accumulation of central neurotransmitter ...by serotonin accumulation, including tachycardia and hypotension, especially if used in combination ...

9

Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues

Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues

... selective serotonin reuptake inhibitor, fluoxetine (FLX), with the atypical antipsychotic drug, olanzapine (OLZ), is supported by the results of four randomized, double-blind, acute phase studies of ...

15

Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study

Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study

... We sought to raise awareness of the issue of depression in the neurological setting by conducting an observational study of the effects of the selective serotonin reuptake inhibitor ([r] ...

10

Show all 7611 documents...

Related subjects